Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study

Meta-Analysis of Direct and Indirect Comparison of Ticagrelor and Prasugrel Effects on Platelet Reactivity

(2015) Thibault Lhermusier et al.   AMERICAN JOURNAL OF CARDIOLOGY

Evaluation of Clinical Risk Factors to Predict High On-Treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE)

(2015) Michal Droppa et al.   PLoS One

Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis

(2014) Dimitrios Alexopoulos et al.   AMERICAN HEART JOURNAL

Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study

(2014) Agnieszka Kaplon-Cieslicka et al.   Cardiovascular Diabetology

PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort

(2014) Bernd Stratmann et al.   Cardiovascular Diabetology

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

(2014) Dominick J. Angiolillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents

(2014) Masanori Taniwaki et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Predictors of antiplatelet response to prasugrel during maintenance treatment

(2014) Katharina Mayer et al.   PLATELETS

Ticagrelor vs prasugrel one-month maintenance therapy: Impact on platelet reactivity and bleeding events

(2014) Katerina Stavrou et al.   THROMBOSIS AND HAEMOSTASIS

Correlation between mean platelet volume and fasting plasma glucose levels in prediabetic and normoglycemic individuals

(2013) Masanori Shimodaira et al.   Cardiovascular Diabetology

Factors Affecting Residual Platelet Aggregation in Prasugrel Treated Patients

(2013) Dimitrios Alexopoulos et al.   CURRENT PHARMACEUTICAL DESIGN

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes

(2013) D. Alexopoulos et al.   DIABETES CARE

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome

(2013) Marc Laine et al.   THROMBOSIS AND HAEMOSTASIS

Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies

(2012) Young-Hoon Jeong et al.   AMERICAN HEART JOURNAL

Prasugrel Monitoring and Bleeding in Real World Patients

(2012) Guillaume Cayla et al.   AMERICAN JOURNAL OF CARDIOLOGY

Third universal definition of myocardial infarction

(2012) Kristian Thygesen et al.   EUROPEAN HEART JOURNAL

Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization

(2012) Paul A. Gurbel   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention

(2012) Dimitrios Alexopoulos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

(2011) José Luis Ferreiro et al.   CIRCULATION

Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention

(2011) Matthew J. Price et al.   CIRCULATION

Predictors and Implications of Stent Thrombosis in Non–ST-Segment Elevation Acute Coronary Syndromes

(2011) Tullio Palmerini et al.   Circulation-Cardiovascular Interventions

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

(2011) Dominick J. Angiolillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel

(2011) Fabio Mangiacapra et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

(2010) Stefan James et al.   EUROPEAN HEART JOURNAL

Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist

(2009) Steen Husted et al.   Cardiovascular Therapeutics

Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38

(2009) Rebecca E. Wrishko et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

(2008) Stephen D. Wiviott et al.   CIRCULATION

Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention

(2008) Giuseppe Patti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY